AMNEAL PHARMACEUTICALS, INC. (AMRX) /

The profitability of AMNEAL PHARMACEUTICALS, INC. over the past 10 years

Chart AMNEAL PHARMACEUTICALS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

AMNEAL PHARMACEUTICALS, INC. reported net income of $72.06M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $1.11B and operating income of $394.1M. It reported a profit in 5 of the 10 years shown, and a loss in fiscal 2018, 2019, 2022, 2023 and 2024. Its highest net income in these years was $91.06M, in fiscal 2020.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$1.11B$394.1M$72.06M
2024ended Dec 31, 2024$1.02B$249.33M-$116.89M
2023ended Dec 31, 2023$820.57M$204.37M-$83.99M
2022ended Dec 31, 2022$784.71M-$94.93M-$129.55M*
2021ended Dec 31, 2021$768.97M$152.72M$10.62M*
2020ended Dec 31, 2020$628.39M$91.16M$91.06M*
2019ended Dec 31, 2019$353M-$248.68M-$361.92M*
2018ended Dec 31, 2018$716.4M-$19.67M-$19.74M
2017ended Dec 31, 2017$526.18M$245.1M$0
2016ended Dec 31, 2016$597.46M$284.88M$0

Fiscal years as AMNEAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on AMNEAL PHARMACEUTICALS, INC.

Companies of a similar size

Not investment advice. This page shows what AMNEAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.